Direct healthcare costs for patients hospitalized with Crimean-Congo haemorrhagic fever can be predicted by a clinical illness severity scoring system

Pathogens and Global Health

Volumn 110, Issue 1, 2016, Pages 9-13

  Bozkurt, Ilkay ^a   Sunbul, Mustafa ^a   Yilmaz, Hava ^a   Esen, Saban ^a   Leblebicioglu, Hakan ^a   Beeching, Nicholas J ^b,c  

^a ONDOKUZ MAYIS UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Crimean Congo hemorrhagic fever; Direct cost; Scoring system

Indexed keywords

ADULT; ARTICLE; COST EFFECTIVENESS ANALYSIS; CRIMEAN CONGO HEMORRHAGIC FEVER; DISEASE SEVERITY; FEMALE; HEALTH CARE COST; HOSPITAL ADMISSION; HOSPITAL COST; HUMAN; MALE; MIDDLE AGED; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; SCORING SYSTEM; AGED; ECONOMICS; HEMORRHAGIC FEVER, CRIMEAN; HOSPITALIZATION; INCIDENCE; LENGTH OF STAY; MORTALITY; NAIROVIRUS; PHYSIOLOGY; SEVERITY OF ILLNESS INDEX; TURKEY; VIROLOGY; YOUNG ADULT;

ADULT; AGED; FEMALE; HEMORRHAGIC FEVER VIRUS, CRIMEAN-CONGO; HEMORRHAGIC FEVER, CRIMEAN; HOSPITAL COSTS; HOSPITALIZATION; HUMANS; INCIDENCE; LENGTH OF STAY; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TURKEY; YOUNG ADULT;

EID: 84978404427     PISSN: 20477724     EISSN: 20477732     Source Type: Journal    
DOI: 10.1080/20477724.2015.1136130     Document Type: Article

References (17)

1. G.R.Yilmaz, T.Buzgan, H.Irmak, A.Safran, R.Uzun, M.A.Cevik. The epidemiology of Crimean-Congo hemorrhagic fever in Turkey, 2002–2007. Int J Infect Dis. 2009 May;13(3):380–386.10.1016/j.ijid.2008.07.021
2. H.Leblebicioglu, H.Bodur, B.Dokuzoguz, N.Elaldi, R.Guner, I.Koksal,. Case management and supportive treatment for patients with Crimean-Congo hemorrhagic fever. Vector Borne Zoonotic Dis. 2012;12(9):805–811.10.1089/vbz.2011.0896
3. H.Leblebicioglu. Crimean-Congo haemorrhagic fever in Eurasia. Int J Antimicrob Agents. 2010;36 Suppl 1:S43–S46.10.1016/j.ijantimicag.2010.06.020
4. M.Sunbul, H.Leblebicioglu, T.E.Fletcher, N.Elaldi, Z.Ozkurt, A.Bastug,. Crimean-Congo haemorrhagic fever and secondary bacteraemia in Turkey. J Infect. 2015;71(5):597–599. doi:10.1016/j.jinf.2015.07.003.
5. M.Bakir, M.Ugurlu, B.Dokuzoguz, H.Bodur, M.A.Tasyaran, H.Vahaboglu,. Crimean-Congo haemorrhagic fever outbreak in middle Anatolia: a multicentre study of clinical features and outcome measures. J Med Microbiol. 2005;54(4):385–389.10.1099/jmm.0.45865-0
6. Z.Ozkurt, I.Kiki, S.Erol, F.Erdem, N.Yilmaz, M.Parlak,. Crimean-Congo hemorrhagic fever in Eastern Turkey: clinical features, risk factors and efficacy of ribavirin therapy. J Infect. 2006;52(3):207–215.10.1016/j.jinf.2005.05.003
7. M.Bakir, A.Engin, M.G.Gozel, N.Elaldi, S.Kilickap, Z.Cinar. A new perspective to determine the severity of cases with Crimean-Congo hemorrhagic fever. J Vector Borne Dis. 2012;49(2):105–110.
8. M.Bakır, M.G.Gözel, I.Köksal, Z.Aşık, Ö.Günal, H.Yılmaz,. Validation of a severity grading score (SGS) system for predicting the course of disease and mortality in patients with Crimean-Congo hemorrhagic fever (CCHF). Eur J Clin Microbiol Infect Dis. 2015;34(2):325–330.10.1007/s10096-014-2238-0
9. B.Dokuzoguz, A.K.Celikbas, Ş.E.Gök, N.Baykam, M.N.Eroglu, Ö.Ergonul. Severity scoring ındex for Crimean-Congo hemorrhagic fever and the ımpact of ribavirin and corticosteroids on fatality. Clin Infect Dis. 2013 Nov;57(9):1270–1274.10.1093/cid/cit527
10. N.Elaldi, H.Bodur, S.Ascioglu, A.Celikbas, Z.Ozkurt, H.Vahaboglu,. Efficacy of oral ribavirin treatment in Crimean-Congo haemorrhagic fever: a quasi-experimental study from Turkey. J Infect. 2009 Mar;58(3):238–244.10.1016/j.jinf.2009.01.014
11. M.G.Gozel, I.Dokmetas, A.Y.Oztop, A.Engin, N.Elaldi, M.Bakir. Recommended precaution procedures protect healthcare workers from Crimean-Congo hemorrhagic fever virus. Int J Infect Dis. 2013 Nov;17(11):e1046–e1050.10.1016/j.ijid.2013.05.005
12. M.Mardani, M.Rahnavardi, M.Rajaeinejad, K.H.Naini, S.Chinikar, F.Pourmalek,. Crimean-Congo hemorrhagic fever among health care workers in Iran: a seroprevalence study in two endemic regions. Am J Trop Med Hyg. 2007;76(3):443–445. PubMed PMID: 17360865.
13. A.Sisman. Epidemiologic features and risk factors of Crimean-Congo hemorrhagic fever in Samsun province. Turkey. J Epidemiol. 2013;23(2):95–102.10.2188/jea.JE20120097
14. H.C.Hekimoglu, N.A.Demirci. Evaluation of cases with a preliminary diagnosis of Crimean-Congo hemorrhagic fever and comparison of characteristics in patients admitted to a secondary care hospital in Kastamonu, Turkey. Afr Health Sci. 2014;14(4):873–881.
15. S.Hosoglu, M.F.Geyik, S.Akalin, C.Ayaz, O.F.Kokoglu, M.Loeb. A simple validated prediction rule to diagnose typhoid fever in Turkey. Trans R Soc Trop Med Hyg. 2006;100:1068–1074.10.1016/j.trstmh.2005.12.007
16. Y.P.Tabak, R.S.Johannes, J.H.Silber. Using automated clinical data for risk adjustment. Med Care. 2007;45:789–805.10.1097/MLR.0b013e31803d3b41
17. G.J.Escobar, J.D.Greene, P.Scheirer, M.N.Gardner, D.Draper, P.Kipnis. Risk-adjusting hospital inpatient mortality using automated inpatient, outpatient, and laboratory databases. Med Care. 2008;46:232–239.10.1097/MLR.0b013e3181589bb6